Parker RA - Search Results

1

Diurnal variation of bone mineral turnover in elderly men and women.

Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L. Greenspan SL, et al. Among authors: parker ra. Calcif Tissue Int. 1997 May;60(5):419-23. doi: 10.1007/s002239900256. Calcif Tissue Int. 1997. PMID: 9115158

2

Biochemical markers of bone turnover reflect femoral bone loss in elderly women.

Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL. Dresner-Pollak R, et al. Among authors: parker ra. Calcif Tissue Int. 1996 Nov;59(5):328-33. doi: 10.1007/s002239900135. Calcif Tissue Int. 1996. PMID: 8849397

3

Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly.

Greenspan SL, Myers ER, Kiel DP, Parker RA, Hayes WC, Resnick NM. Greenspan SL, et al. Among authors: parker ra. Am J Med. 1998 Jun;104(6):539-45. doi: 10.1016/s0002-9343(98)00115-6. Am J Med. 1998. PMID: 9674716

4

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.

Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB. Greenspan SL, et al. Among authors: parker ra. J Bone Miner Res. 1998 Sep;13(9):1431-8. doi: 10.1359/jbmr.1998.13.9.1431. J Bone Miner Res. 1998. PMID: 9738515 Free article. Clinical Trial.

5

Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis.

Varney LF, Parker RA, Vincelette A, Greenspan SL. Varney LF, et al. Among authors: parker ra. J Clin Densitom. 1999 Fall;2(3):275-83. doi: 10.1385/jcd:2:3:275. J Clin Densitom. 1999. PMID: 10548823

6

Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women.

Bouxsein ML, Parker RA, Greenspan SL. Bouxsein ML, et al. Among authors: parker ra. Osteoporos Int. 1999;10(6):505-9. doi: 10.1007/s001980050261. Osteoporos Int. 1999. PMID: 10663352 Clinical Trial.

7

Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women.

Greenspan SL, Rosen HN, Parker RA. Greenspan SL, et al. Among authors: parker ra. J Clin Endocrinol Metab. 2000 Oct;85(10):3537-40. doi: 10.1210/jcem.85.10.6911. J Clin Endocrinol Metab. 2000. PMID: 11061497 Clinical Trial.

8

Classification of osteoporosis and osteopenia in men is dependent on site-specific analysis.

Stoch SA, Wysong E, Connolly C, Parker RA, Greenspan SL. Stoch SA, et al. Among authors: parker ra. J Clin Densitom. 2000 Winter;3(4):311-7. doi: 10.1385/jcd:3:4:311. J Clin Densitom. 2000. PMID: 11175910

9

Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists.

Stoch SA, Parker RA, Chen L, Bubley G, Ko YJ, Vincelette A, Greenspan SL. Stoch SA, et al. Among authors: parker ra. J Clin Endocrinol Metab. 2001 Jun;86(6):2787-91. doi: 10.1210/jcem.86.6.7558. J Clin Endocrinol Metab. 2001. PMID: 11397888

10

Why do older women discontinue hormone replacement therapy?

Regan MM, Emond SK, Attardo MJ, Parker RA, Greenspan SL. Regan MM, et al. Among authors: parker ra. J Womens Health Gend Based Med. 2001 May;10(4):343-50. doi: 10.1089/152460901750269661. J Womens Health Gend Based Med. 2001. PMID: 11445025 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters